The RxPONDER trial results were presented this year at the San Antonio Breast Cancer Symposium 2020. The study was investigating if some women with...

10 December 2020

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “While this Plan to recover and redesign cancer services in Scotland...

10 December 2020

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “Today’s announcement includes funding for both the NHS and...

25 November 2020

NHS England cancer waiting times data from September 2020 shows: The two week wait target for people referred with suspected breast cancer was...

12 November 2020

Baroness Delyth Morgan, Chief Executive of Breast Cancer Now, said: While we’ve known for some time that HRT increases the risk of breast...

10 November 2020

Baroness Delyth Morgan, Chief Executive of Breast Cancer Now, said, It’s is deeply concerning that 40% of charity-funded early career...

10 November 2020

Mia Rosenblatt, Associate Director of Policy and Influencing at Breast Cancer Now, said: “We are very concerned that often there can be...

9 November 2020

The Scottish Medicines Consortium (SMC) has today (9 November 2020) approved: Trastuzumab emtansine (Kadcyla) for routine NHS use in Scotland...

9 November 2020

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It is cause for great concern that almost half (48%) of the people...

9 October 2020